MANNKIND CORP Operating Cash Flow
MANNKIND CORP (MNKD) reported Operating Cash Flow of -$23.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- MANNKIND CORP net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$18.37M, a 305.26% decline year-over-year.
- MANNKIND CORP net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$5.37M.
- MANNKIND CORP net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$7.96M, a 135.14% decline year-over-year.
- MANNKIND CORP net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $23.64M, a 153.35% increase year-over-year.
- MANNKIND CORP net cash provided by (used in) operating activities for fiscal 2025 was $18.25M, a 57.06% decline from fiscal 2024.
- MANNKIND CORP net cash provided by (used in) operating activities for fiscal 2024 was $42.51M, a 24.69% increase from fiscal 2023.
- MANNKIND CORP net cash provided by (used in) operating activities for fiscal 2023 was $34.09M.
- MANNKIND CORP net cash provided by (used in) operating activities for fiscal 2022 was -$80.68M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 244 month | Net Cash Provided by (Used in) Operating Activities 247 month | Net Cash Provided by (Used in) Operating Activities 250 month | Net Cash Provided by (Used in) Operating Activities 253 month | Net Cash Provided by (Used in) Operating Activities 256 month | Net Cash Provided by (Used in) Operating Activities 259 month | Net Cash Provided by (Used in) Operating Activities 263 month | Net Cash Provided by (Used in) Operating Activities 265 month | Net Cash Provided by (Used in) Operating Activities 268 month | Net Cash Provided by (Used in) Operating Activities 271 month | Net Cash Provided by (Used in) Operating Activities 275 month | Net Cash Provided by (Used in) Operating Activities 277 month | Net Cash Provided by (Used in) Operating Activities 280 month | Net Cash Provided by (Used in) Operating Activities 283 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$18.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$23.74M 10-Q · filed 2026-08-05 | -$31.69M derived: sum of 3 quarters · filed 2026-08-05 | -$8.05M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2026-03-31 | -$5.37M 10-Q · filed 2026-05-06 | -$13.32M derived: sum of 2 quarters · filed 2026-05-06 | $10.32M derived: sum of 3 quarters · filed 2026-05-06 | $19.27M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2025-12-31 | -$7.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.68M derived: sum of 2 quarters · filed 2026-02-26 | $24.63M derived: sum of 3 quarters · filed 2026-08-05 | $18.25M 10-K · filed 2026-02-26 | ||||||||||||||
| 2025-09-30 | $23.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $32.59M derived: sum of 2 quarters · filed 2026-08-05 | $26.21M 10-Q · filed 2025-11-05 | $48.86M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2025-06-30 | $8.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.57M 10-Q · filed 2026-08-05 | $25.22M derived: sum of 3 quarters · filed 2026-08-05 | $34.55M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2025-03-31 | -$6.38M 10-Q · filed 2026-05-06 | $16.27M derived: sum of 2 quarters · filed 2026-05-06 | $25.60M derived: sum of 3 quarters · filed 2026-05-06 | $29.43M derived: sum of 4 quarters · filed 2026-05-06 | ||||||||||||||
| 2024-12-31 | $22.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $31.98M derived: sum of 2 quarters · filed 2026-02-26 | $35.81M derived: sum of 3 quarters · filed 2026-02-26 | $42.51M 10-K · filed 2026-02-26 | ||||||||||||||
| 2024-09-30 | $9.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $13.16M derived: sum of 2 quarters · filed 2025-11-05 | $19.87M 10-Q · filed 2025-11-05 | $41.55M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||
| 2024-06-30 | $3.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $10.54M 10-Q · filed 2025-08-06 | $32.21M derived: sum of 3 quarters · filed 2026-02-26 | $40.88M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||
| 2024-03-31 | $6.70M 10-Q · filed 2025-05-08 | $28.38M derived: sum of 2 quarters · filed 2026-02-26 | $37.05M derived: sum of 3 quarters · filed 2026-02-26 | $39.64M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||
| 2023-12-31 | $21.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $30.34M derived: sum of 2 quarters · filed 2026-02-26 | $32.94M derived: sum of 3 quarters · filed 2026-02-26 | $34.09M 10-K · filed 2026-02-26 | ||||||||||||||
| 2023-09-30 | $8.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $11.26M derived: sum of 2 quarters · filed 2024-11-07 | $12.42M 10-Q · filed 2024-11-07 | $10.04M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||||||||
| 2023-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $3.75M 10-Q · filed 2024-08-07 | $1.38M derived: sum of 3 quarters · filed 2025-02-26 | -$26.70M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||||||||
| 2023-03-31 | $1.16M 10-Q · filed 2024-05-08 | -$1.22M derived: sum of 2 quarters · filed 2025-02-26 | -$29.29M derived: sum of 3 quarters · filed 2025-02-26 | -$61.27M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||||||||
| 2022-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$30.45M derived: sum of 2 quarters · filed 2025-02-26 | -$62.43M derived: sum of 3 quarters · filed 2025-02-26 | -$80.68M 10-K · filed 2025-02-26 | ||||||||||||||
| 2022-09-30 | -$28.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$60.05M derived: sum of 2 quarters · filed 2023-11-07 | -$78.30M 10-Q · filed 2023-11-07 | -$90.65M derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||
| 2022-06-30 | -$31.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$50.23M 10-Q · filed 2023-08-07 | -$62.58M derived: sum of 3 quarters · filed 2024-02-27 | -$77.76M derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||
| 2022-03-31 | -$18.25M 10-Q · filed 2023-05-09 | -$30.59M derived: sum of 2 quarters · filed 2024-02-27 | -$45.78M derived: sum of 3 quarters · filed 2024-02-27 | -$67.23M derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||
| 2021-12-31 | -$12.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$27.53M derived: sum of 2 quarters · filed 2024-02-27 | -$48.98M derived: sum of 3 quarters · filed 2024-02-27 | -$61.71M 10-K · filed 2024-02-27 | ||||||||||||||
| 2021-09-30 | -$15.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$36.63M derived: sum of 2 quarters · filed 2022-11-08 | -$49.36M 10-Q · filed 2022-11-08 | -$49.13M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||
| 2021-06-30 | -$21.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$34.18M 10-Q · filed 2022-08-09 | -$33.94M derived: sum of 3 quarters · filed 2023-02-23 | -$47.40M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||
| 2021-03-31 | -$12.73M 10-Q · filed 2022-05-05 | -$12.50M derived: sum of 2 quarters · filed 2023-02-23 | -$25.96M derived: sum of 3 quarters · filed 2023-02-23 | -$29.64M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||
| 2020-12-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$13.22M derived: sum of 2 quarters · filed 2023-02-23 | -$16.91M derived: sum of 3 quarters · filed 2023-02-23 | -$28.13M 10-K · filed 2023-02-23 | ||||||||||||||
| 2020-09-30 | -$13.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$17.14M derived: sum of 2 quarters · filed 2021-11-09 | -$28.36M 10-Q · filed 2021-11-09 | -$33.47M derived: sum of 4 quarters · filed 2021-11-09 | ||||||||||||||
| 2020-06-30 | -$3.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$14.90M 10-Q · filed 2021-08-11 | -$20.01M derived: sum of 3 quarters · filed 2021-08-11 | -$72.06M derived: sum of 4 quarters · filed 2021-08-11 | ||||||||||||||
| 2020-03-31 | -$11.22M 10-Q · filed 2021-05-12 | -$16.33M derived: sum of 2 quarters · filed 2021-05-12 | -$68.38M derived: sum of 3 quarters · filed 2021-05-12 | -$88.11M derived: sum of 4 quarters · filed 2021-05-12 | ||||||||||||||
| 2019-12-31 | -$5.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$57.16M derived: sum of 2 quarters · filed 2021-02-25 | -$76.89M derived: sum of 3 quarters · filed 2021-02-25 | -$88.48M 10-K · filed 2021-02-25 | ||||||||||||||
| 2019-09-30 | -$52.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$71.78M derived: sum of 2 quarters · filed 2020-11-04 | -$83.38M 10-Q · filed 2020-11-04 | -$58.39M derived: sum of 4 quarters · filed 2020-11-04 | ||||||||||||||
| 2019-06-30 | -$19.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$31.32M 10-Q · filed 2020-08-05 | -$6.34M derived: sum of 3 quarters · filed 2020-08-05 | -$20.26M derived: sum of 4 quarters · filed 2020-08-05 | ||||||||||||||
| 2019-03-31 | -$11.60M 10-Q · filed 2020-05-06 | $13.39M derived: sum of 2 quarters · filed 2020-05-06 | -$528.00K derived: sum of 3 quarters · filed 2020-05-06 | -$27.68M derived: sum of 4 quarters · filed 2020-05-06 | ||||||||||||||
| 2018-12-31 | $24.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $11.07M derived: sum of 2 quarters · filed 2020-02-25 | -$16.08M derived: sum of 3 quarters · filed 2020-02-25 | -$37.73M 10-K · filed 2020-02-25 | ||||||||||||||
| 2018-09-30 | -$13.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$41.07M derived: sum of 2 quarters · filed 2019-11-08 | -$62.72M 10-Q · filed 2019-11-08 | -$92.70M derived: sum of 4 quarters · filed 2019-11-08 | ||||||||||||||
| 2018-06-30 | -$27.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$48.80M 10-Q · filed 2019-08-07 | -$78.78M derived: sum of 3 quarters · filed 2019-08-07 | -$102.05M derived: sum of 4 quarters · filed 2019-08-07 | ||||||||||||||
| 2018-03-31 | -$21.65M 10-Q · filed 2019-05-07 | -$51.63M derived: sum of 2 quarters · filed 2019-05-07 | -$74.90M derived: sum of 3 quarters · filed 2019-05-07 | |||||||||||||||
| 2017-12-31 | -$29.98M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$53.25M derived: sum of 2 quarters · filed 2019-02-26 | -$64.78M 10-K · filed 2019-02-26 | |||||||||||||||
| 2017-09-30 | -$23.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$34.80M 10-Q · filed 2018-11-01 | ||||||||||||||||
| 2017-06-30 | -$11.53M 10-Q · filed 2018-08-02 | |||||||||||||||||
| 2016-12-31 | -$78.09M 10-K · filed 2019-02-26 | |||||||||||||||||
| 2014-09-30 | $1.70B 10-Q · filed 2014-11-10 | |||||||||||||||||
| 2014-06-30 | -$1.80B 10-Q · filed 2014-08-11 | |||||||||||||||||
| 2014-03-31 | -$1.76B 10-Q · filed 2014-05-12 | |||||||||||||||||
| 2013-12-31 | -$34.05M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$66.96M derived: sum of 2 quarters · filed 2014-03-03 | -$96.70M derived: sum of 3 quarters · filed 2014-03-03 | -$128.73M 10-K · filed 2014-03-03 | -$1.72B 10-K · filed 2014-03-03 | |||||||||||||
| 2013-09-30 | -$32.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$62.65M derived: sum of 2 quarters · filed 2013-11-12 | -$94.68M 10-Q · filed 2013-11-12 | -$122.78M derived: sum of 4 quarters · filed 2014-03-03 | -$1.69B 10-Q · filed 2013-11-12 | |||||||||||||
| 2013-06-30 | -$29.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$61.77M 10-Q · filed 2013-08-09 | -$89.87M derived: sum of 3 quarters · filed 2014-03-03 | -$124.13M derived: sum of 4 quarters · filed 2014-03-03 | -$1.66B 10-Q · filed 2013-08-09 | |||||||||||||
| 2013-03-31 | -$32.03M 10-Q · filed 2013-05-10 | -$60.13M derived: sum of 2 quarters · filed 2014-03-03 | -$94.38M derived: sum of 3 quarters · filed 2014-03-03 | -$119.40M derived: sum of 4 quarters · filed 2014-03-03 | -$1.63B 10-Q · filed 2013-05-10 | |||||||||||||
| 2012-12-31 | -$28.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$62.36M derived: sum of 2 quarters · filed 2014-03-03 | -$87.37M derived: sum of 3 quarters · filed 2014-03-03 | -$119.86M 10-K · filed 2014-03-03 | -$1.60B 10-K · filed 2013-03-18 | |||||||||||||
| 2012-09-30 | -$34.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$59.28M derived: sum of 2 quarters · filed 2013-11-12 | -$91.76M 10-Q · filed 2013-11-12 | -$112.12M derived: sum of 4 quarters · filed 2014-03-03 | -$1.57B 10-Q · filed 2012-11-09 | |||||||||||||
| 2012-06-30 | -$25.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$57.50M 10-Q · filed 2013-08-09 | -$77.86M derived: sum of 3 quarters · filed 2014-03-03 | -$113.89M derived: sum of 4 quarters · filed 2014-03-03 | -$1.53B 10-Q · filed 2012-08-09 | |||||||||||||
| 2012-03-31 | -$32.49M 10-Q · filed 2013-05-10 | -$52.84M derived: sum of 2 quarters · filed 2014-03-03 | -$88.88M derived: sum of 3 quarters · filed 2014-03-03 | -$125.62M derived: sum of 4 quarters · filed 2014-03-03 | -$1.51B 10-Q · filed 2012-05-10 | |||||||||||||
| 2011-12-31 | -$20.36M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$56.39M derived: sum of 2 quarters · filed 2014-03-03 | -$93.13M derived: sum of 3 quarters · filed 2014-03-03 | -$123.84M 10-K · filed 2014-03-03 | -$1.48B 10-K · filed 2012-03-15 | |||||||||||||
| 2011-09-30 | -$36.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$72.78M derived: sum of 2 quarters · filed 2012-11-09 | -$103.48M 10-Q · filed 2012-11-09 | -$142.45M derived: sum of 4 quarters · filed 2013-03-18 | -$1.46B 10-Q · filed 2011-11-04 | |||||||||||||
| 2011-06-30 | -$36.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$67.45M 10-Q · filed 2012-08-09 | -$106.42M derived: sum of 3 quarters · filed 2013-03-18 | -$141.27M derived: sum of 4 quarters · filed 2013-03-18 | -$1.42B 10-Q · filed 2011-08-04 | |||||||||||||
| 2011-03-31 | -$30.70M 10-Q · filed 2012-05-10 | -$69.68M derived: sum of 2 quarters · filed 2013-03-18 | -$104.52M derived: sum of 3 quarters · filed 2013-03-18 | |||||||||||||||
| 2010-12-31 | -$38.97M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$73.82M derived: sum of 2 quarters · filed 2013-03-18 | -$148.65M 10-K · filed 2013-03-18 | |||||||||||||||
| 2010-09-30 | -$34.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$109.68M 10-Q · filed 2011-11-04 | ||||||||||||||||
| 2010-06-30 | -$74.83M 10-Q · filed 2011-08-04 | |||||||||||||||||
| 2009-12-31 | -$184.08M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |